Here are the 10-Q quarterly reports from Vicor Corp (VICR) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow VICR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VICR filings page.
Vicor Corporation reported third-quarter 2026 net revenues of $197.1 million, up 78.5% from $110.4 million in the third quarter of 2025. Royalty revenue was $66.6 million, compared with $21.7 million a year earlier. Management attributed Advanced Products growth primarily to higher royalty revenue under a new license agreement entered during the quarter and improved market demand. Gross margin was $134.7 million, or 68.3% of net revenues, compared with $63.5 million and 57.5% a year earlier.
Net income attributable to Vicor was $63.3 million, or $1.33 per diluted share, compared with $28.3 million and $0.63. Selling, general and administrative expense rose 69.5% to $38.6 million; higher legal fees contributed $13.9 million of the increase. For the first nine months of 2026, operating cash flow was $80.4 million, compared with $123.8 million in the same period of 2025. Cash and cash equivalents were $513.1 million at September 30, 2026.
Vicor Corporation reported sharply stronger results for the first quarter of 2026. Total net revenues rose to $112.97 million, up 20.2% from a year earlier, driven by higher demand for both Advanced and Brick Products and increased royalty revenue. Gross margin expanded to 55.2% of revenue, from 47.2%, reflecting better mix and production efficiencies despite higher freight and tariff costs.
Operating income reached $16.88 million versus a small loss a year ago, and net income attributable to Vicor jumped to $20.66 million, or $0.44 per diluted share, compared with $0.06 per share. The company ended the quarter with $404.25 million in cash and cash equivalents and a strong current ratio of 14.3:1. Backlog scheduled within 12 months increased to $300.62 million. During the quarter Vicor paid $28.56 million to settle the SynQor patent judgment and maintained $25.31 million in capital expenditure commitments while continuing to invest in manufacturing capacity.
Vicor Corporation (VICR) reported stronger Q3 2025 results. Net revenues were $110.423 million, up 18.5% year over year. Gross margin was $63.513 million, representing 57.5%. Net income attributable to Vicor was $28.292 million, or $0.63 per diluted share, versus $0.26 a year ago.
Advanced Products including royalty revenue contributed $65.506 million, while Brick Products delivered $44.917 million. By geography, Q3 revenue was $63.180 million in the United States, $10.882 million in Europe, $35.434 million in Asia Pacific, and $0.927 million in all other regions. Backlog scheduled within 12 months was approximately $152.809 million at quarter end.
Cash and cash equivalents were $362.382 million at September 30, 2025. Year to date, net cash provided by operating activities was $123.840 million, capital additions were $14.775 million, and repurchases of Common Stock totaled $32.978 million. The company recorded a $45.000 million patent litigation settlement in Q2 2025 and $5.100 million of related legal fees year to date. The effective tax rate for Q3 was a benefit of 21.4%, reflecting the One Big Beautiful Bill Act provisions and a domestic valuation allowance position.
Vicor (VICR) posted a sharp turnaround for Q2 2025. Total revenue plus a $45 m patent-litigation settlement reached $141.0 m; product+royalty revenue alone rose 11.9 % YoY to $96.0 m. Gross margin expanded to 65.3 % (47.1 % ex-settlement) and operating income jumped to $45.4 m from $0.2 m. Net income swung to $41.2 m ($0.91 diluted EPS) versus a $1.2 m loss in Q2 2024.
Growth was led by Advanced Products. Advanced revenue climbed 30.6 % to $60.6 m, while Brick Products fell 10.1 % to $35.5 m. Asia-Pacific sales surged 44 % and now represent 40 % of quarterly revenue; U.S. sales declined 5 %. Royalty income improved 11.6 % to $10.4 m.
Balance-sheet strength improved. Cash & equivalents increased $61 m Q-to-Q to $338.5 m, supported by $85.4 m operating cash flow and the settlement. Inventories fell 10 % YTD, while share repurchases totaled $17.6 m. The company remains debt-free but carries a $27.6 m litigation accrual tied to the SynQor patent case, with post-judgment interest still accruing. Backlog slipped 10 % sequentially to $155.2 m, hinting at potential near-term demand moderation.